The HSE’s RSV immunisation programme available in Wexford

The HSE is extending its RSV immunisation programme to all babies in Ireland born from 1 March 2025 to 31 August 2025 in Wexford. This immunisation programme is also available in maternity settings to all babies born in Ireland from 1 September 2025 to 28 February 2026.

Patricial McQuillan, Director of Nursing, Regional Vaccination Programme, Health & Wellbeing, IHA Carlow/Kilkenny/Tipperary South & IHA Waterford/Wexford says: “Every winter, Respiratory Syncytial Virus (RSV) infection causes serious illness, including hospitalisations, especially among young infants. “In the Wexford area, we are advising parents of those babies eligible to get this immunisation to ensure their children are protected ahead of the winter. “For the babies born from 1 March 2025 to 31 August 2025, we have immunisation clinics running, for example, in our primary care centres and health centres in Gorey, Wexford town and New Ross.” How to get your baby immunised: Parents and guardians of babies born from 1 March 2025 to 31 August 2025 can book an appointment at https://www2.hse.ie/conditions/rsv/immunisation/. These appointments will only be available from 1 September 2025 and until the first week in October 2025. Parents and guardians are advised to book early to ensure their child is protected ahead of any surge in RSV infections later in the autumn/winter. The HSE winter infant RSV programme clinics in Wexford take place at: 15 September - 9am to 1pm and 2pm to 4pm Wexford Vaccination Centre, St John’s Hospital, Enniscorthy, 16 September - 9am to 1pm and 2pm to 4pm Gorey Health Centre, Gorey Corporation Lands, Gorey, 17 September- 9am to 1pm and 2pm to 4pm Wexford Primary Care Centre, Grogan’s Road, Wexford Town 18 September - 9am to 1pm and 2pm to 4pm New Ross Health Centre, Hospital Grounds, New Ross For babies born from 1 September 2025 to 28 February 2026, their parents and guardians will be offered the immunisation before the baby leaves the maternity hospital. The RSV immunisation programme is being delivered by trained midwives in maternity settings after birth and before the baby is discharged and by vaccination teams in the community for children born since 1st of March 2025 until 31st of August 2025, as well as at home for higher risk babies (including those who are premature). Further information on the HSE RSV immunisation programme is available at https://www2.hse.ie/conditions/rsv/immunisation/

More from Wexford News

  • Get Involved in Team Hope’s Christmas Shoebox Appeal

    Schools across Wexford are being called upon to support children living in poverty around the world by participating in Ireland's most loved Christmas appeal – the Team Hope Christmas Shoebox Appeal. As the charity celebrates its 15th year of spreading festive joy, Team Hope is inviting schools, employers, individuals and community organizations across Wexford to take part by registering online at teamhope.ie.

  • Wexford Volunteers Remove 4.1 Tonnes of Marine Litter During Big Beach Clean 2025

    In a monumental effort to protect Ireland’s marine environment, 695 volunteers across Wexford helped remove an estimated 4.1 tonnes of marine litter during the Big Beach Clean 2025. Part of An Taisce’s Clean Coasts Programme, this national event engaged almost 11,000 volunteers who cleaned up 520 locations nationwide, collecting over 60 tonnes of litter—the equivalent weight of around 9 elephants!

  • Wallace Criticizes Western Policies

    Former MEP Mick Wallace has passionately critiqued the role of big money in U.S. politics, European complicity in Gaza and the destructive impact of conflicts like the war in Ukraine.

  • Low Awareness of RSV Risks Among Older Adults in Wexford

    A recent study has revealed that awareness of Respiratory Syncytial Virus (RSV) is alarmingly low among older adults and their carers in Wexford and across Ireland. Despite RSV being a significant cause of hospitalisations, particularly for those aged 65 and over, only 18% of people report knowing much about the virus. The study, commissioned by Pfizer and conducted by Ipsos B&A, shows that 41% of respondents have never heard of RSV or only recognize the name.